Similar articles

• Prostacyclin, thromboxane and prostaglandin F2 alpha in suction blister fluid of human skin: effect of systemic aspirin and local glucocorticosteroid treatment.

  Oikarinen A, Viinikka L, Rytsälä H, Kiistala U, Ylikorkala O. Oikarinen A, et al. Life Sci. 1981 Jul 27;29(4):391-6. doi: 10.1016/0024-3205(81)90332-5. Life Sci. 1981. PMID: 7024698 Clinical Trial. No abstract available.
• Relative insensitivity of epinephrine induced platelet aggregation to prostacyclin.

  Zahavi M, Zahavi J. Zahavi M, et al. Thromb Res. 1986 Oct 1;44(1):119-24. doi: 10.1016/0049-3848(86)90187-8. Thromb Res. 1986. PMID: 3538494 No abstract available.
• Metabolic fate of thromboxane A2 and prostacyclin.

  Roberts LJ 2nd, Brash AR, Oates JA. Roberts LJ 2nd, et al. Adv Prostaglandin Thromboxane Leukot Res. 1982;10:211-25. Adv Prostaglandin Thromboxane Leukot Res. 1982. PMID: 6216783 Review. No abstract available.
• Dosage frequency for suppression of platelet function by low dose aspirin therapy.

  Bradlow BA, Chetty N. Bradlow BA, et al. Thromb Res. 1982 Jul 1;27(1):99-110. doi: 10.1016/0049-3848(82)90283-3. Thromb Res. 1982. PMID: 7123514
• Aspirin resistance.

  Tantry US, Mahla E, Gurbel PA. Tantry US, et al. Prog Cardiovasc Dis. 2009 Sep-Oct;52(2):141-52. doi: 10.1016/j.pcad.2009.05.001. Prog Cardiovasc Dis. 2009. PMID: 19732606 Review. No abstract available.